3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Amentia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Amentia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Costa, DC; Janssen, AG; Katona, CL; Livingstone, G; Walker, RW; Walker, Z	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Amentia

Article	Year
Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Aged; Alzheimer Disease; Benzamides; Brain; Contrast Media; Dementia; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Male; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	1997

Article

Year

Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.

European journal of nuclear medicine, 1997, Volume: 24, Issue:6

Topics: Aged; Alzheimer Disease; Benzamides; Brain; Contrast Media; Dementia; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Male; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1997